Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A double-blind, placebo controlled, randomised, parallel group, single centre, phase IIa study to investigate the efficacy, tolerability and safety of 8 doses of AZD8848 administered intranasally once weekly in mild to moderate allergic asthma patients challenged with an inhaled allergen https://kusajili.com:443/Trial/Rd92yr8f4kudQyniUKb1zA%24a-double-blind-placebo-controlled-randomised-parallel-group-single-centre-phase-iia-study-to-investigate-the-efficacy-tolerabil
I have read and accept the terms of use of the site and the Privacy Policy
Send your message